Valantin MA - Search Results

1

Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART.

Nouchi A, Nguyen T, Valantin MA, Simon A, Sayon S, Agher R, Calvez V, Katlama C, Marcelin AG, Soulie C. Nouchi A, et al. Among authors: valantin ma. J Antimicrob Chemother. 2018 Aug 1;73(8):2141-2146. doi: 10.1093/jac/dky130. J Antimicrob Chemother. 2018. PMID: 29846589

2

Renal insufficiency induced by ritonavir in HIV-infected patients.

Bochet MV, Jacquiaud C, Valantin MA, Katlama C, Deray G. Bochet MV, et al. Among authors: valantin ma. Am J Med. 1998 Nov;105(5):457. Am J Med. 1998. PMID: 9831435 No abstract available.

3

[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].

Mouroux M, Bossi P, Yvon-Groussin A, Delaugerre C, Valantin MA, Tubiana R, Coutellier A, Bonmarchand M, Bricaire F, Katlama C, Agut H, Huraux JM, Calvez V. Mouroux M, et al. Among authors: valantin ma. Pathol Biol (Paris). 1999 May;47(5):549-52. Pathol Biol (Paris). 1999. PMID: 10418038 French.

4

[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T].

Mouroux M, Izopet J, Descamps D, Delaugerre C, Yvon-Groussin A, Angleraud F, Coutellier A, Bonmarchand M, Valantin MA, Matheron S, Agut H, Katlama C, Brun-Vezinet F, Calvez V. Mouroux M, et al. Among authors: valantin ma. Pathol Biol (Paris). 2000 Jun;48(5):508-12. Pathol Biol (Paris). 2000. PMID: 10949850 French.

5

Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy.

Baril L, Beucler I, Valantin MA, Bruckert E, Bonnefont-Rousselot D, Coutellier A, Caumes E, Katlama C, Bricaire F. Baril L, et al. Among authors: valantin ma. AIDS. 2001 Feb 16;15(3):415-7. doi: 10.1097/00002030-200102160-00016. AIDS. 2001. PMID: 11273223 No abstract available.

6

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.

Delaugerre C, Valantin MA, Mouroux M, Bonmarchand M, Carcelain G, Duvivier C, Tubiana R, Simon A, Bricaire F, Agut H, Autran B, Katlama C, Calvez V. Delaugerre C, et al. Among authors: valantin ma. AIDS. 2001 Nov 9;15(16):2189-91. doi: 10.1097/00002030-200111090-00016. AIDS. 2001. PMID: 11684940 Clinical Trial.

7

Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.

Mouroux M, Descamps D, Izopet J, Yvon A, Delaugerre C, Matheron S, Coutellier A, Valantin MA, Bonmarchand M, Agut H, Massip P, Costagliola D, Katlama C, Brun-Vezinet F, Calvez V. Mouroux M, et al. Among authors: valantin ma. Antivir Ther. 2001 Sep;6(3):179-83. Antivir Ther. 2001. PMID: 11808752

8

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.

Calvez V, Costagliola D, Descamps D, Yvon A, Collin G, Cécile A, Delaugerre C, Damond F, Marcelin AG, Matheron S, Simon A, Valantin MA, Katlama C, Brun-Vézinet F. Calvez V, et al. Among authors: valantin ma. Antivir Ther. 2002 Sep;7(3):211-8. Antivir Ther. 2002. PMID: 12487389

9

Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, Bousquet R, Katz P, Costagliola D, Katlama C. Valantin MA, et al. AIDS. 2003 Nov 21;17(17):2471-7. doi: 10.1097/00002030-200311210-00009. AIDS. 2003. PMID: 14600518

10

Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.

Wirden M, Marcelin AG, Tubiana R, Valantin MA, Ghosn J, Duvivier C, Dominguez S, Paris L, Agher R, Peytavin G, Katlama C, Calvez V. Wirden M, et al. Among authors: valantin ma. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):876-8. doi: 10.1097/00126334-200407010-00016. J Acquir Immune Defic Syndr. 2004. PMID: 15213573 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters